Valley View company begins clinical study with University of Cincinnati

A few weeks after receiving additional patent coverage, Great Lakes NeuroTechnologies has launched a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with Parkinson’s disease (PD). The NIH-funded study is being conducted in partnership with Dr. Alberto Espay of the University of Cincinnati and Dr. Peter LeWitt of HenryFord Health System in Detroit.

Researchers and companies around the world are investigating new treatments intended to slow the progression of PD. Demonstrating the efficacy of these types of proposed neuroprotective therapies can be challenging since very small changes over long periods of time must be measured. The current standard for evaluation of PD motor symptom severity and progression is the Unified Parkinson’s Disease Rating Scale (UPDRS), a subjective scoring system relying on clinician observations to rate symptom severity on 0-4 scale.

Using a system like Kinesia, with high sensitivity motion sensors to measure those changes, can provide several advantages when combined with clinical rating scales. As a unique part of the study design, Parkinson’s patients implanted with deep brain stimulation devices will be recruited for the study. Slowly adjusting the stimulation settings will allow researchers to simulate worsening symptoms and disease progression that would normally take years to study.

Learn more about the clinical study in the company’s press release.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

HealthSpot and CareSource team to improve access to healthcare | BusinessWire, August 20, 2014

EnvisionRxOptions named to Inc. Magazine’s The Inc. 500|5000″ list of America’s fastest-growing companies for second consecutive year | Herald Online, August 20, 2014

Forty attorneys from member firm McNees Wallace & Nurick recognized as Best Lawyers in America | McNees Wallace & Nurick, August 19, 2014

Minimally Invasive Devices and Mitsubishi Medical Japan forge exclusive distribution agreement | PR Newswire, August 19, 2014

Summa Health System President and CEO Thomas Strauss will retire at end of 2014 | Crains Cleveland, August 19, 2014

New device at Ohio State Wexner Medical Center takes aim at cluster headaches | WBNS 10TV Columbus, August 18, 2014

BioOhio Blog: OffWhite reflects on the BioOhio Expo, education is the best kind of marketing | BioOhio, August 15, 2014

$2.71M allocated to improve colleges and universities around Ohio | Cleveland.com, August 15, 2014

ChanTest announces a global campaign to share new findings and developments in cystic fibrosis research | PR Web, August 14, 2014

Cleveland Clinic cancer center gets thumbs-up from city design review committee | The Plain Dealer, August 14, 2014

Cleveland Clinic Chief of Staff Dr. Joseph Hahn to retire after nearly four decades as a neurosurgeon, leader and innovator | The Plain Dealer, August 14, 2014

Senator Rob Portman visits Assurex Health to learn about tests to help veterans struggling with post-traumatic stress disorders and other mental illnesses | Cincinnati.com, August 13, 2014

Collaboration between Miami Valley Hospital and Dayton Children’s Hospital to provide care for high-risk pregnancies and at-risk newborns | PR Web, August 13, 2014

Bacterial Robotics building bactobots engineered to destroy skull-based tumors | MedCity News, August 12, 2014

Lindsey Burns, Clincial Development Associate at Assurex Health, named a 2014 Professional Woman of the Year by the National Association of Professional Women | PR Web, August 12, 2014

Juventas Therapeutics completes enrollment of Phase I/II RETRO-HF trial and demonstrates safety for retrograde infusion of JVS-100 in patients with heart failure | PR Newswire, August 12, 2014

Trends driving Cincinnati’s health care building boom | Cincinnati.com, August 12, 2014

AdvaMed President and CEO Stephen Ubl, Medical-device tax should be repealed | Columbus Dispatch, August 12, 2014

Assurex Health marks 100,000 patients tested with GeneSight to support medication selection | Assurex Health, August 12, 2014

New BioOhio contributor blog post: eCTD Global Submission Planners Case Study presented by Auditgraph | BioOhio, August 11, 2014